Majoven Xl

Venlafaxine Hydrochloride, the active ingredient in Majoven Xl, is a serotonin‑norepinephrine reuptake inhibitor (SNRI) presented as an oral tablet for oral use. It is prescribed for several mood‑related disorders in adult patients. GNH USA supplies Majoven Xl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Venlafaxine Hydrochloride is an SNRI indicated for several psychiatric conditions. - Major depressive disorder: reduces depressive symptoms and improves overall mood. - Generalized anxiety disorder: lessens excessive worry and associated physical tension. - Social anxiety disorder: diminishes fear of social situations and improves functional performance. - Panic disorder: decreases frequency and intensity of panic attacks.

Venlafaxine Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dry mouth: reduced salivation. - Insomnia: difficulty falling or staying asleep. - Dizziness: sensation of light‑headedness. - Sweating: increased perspiration.

Serious or Rare Side Effects: - Serotonin syndrome: potentially life‑threatening condition with agitation, hyperthermia, and neuromuscular abnormalities. - Hypertension: elevated blood pressure requiring monitoring. - Suicidal thoughts: emergence of suicidal ideation, especially in early treatment. - Severe hyponatremia: low sodium levels causing confusion or seizures. - Cardiac arrhythmia: abnormal heart rhythm in susceptible individuals. - Anaphylaxis: rare severe allergic reaction with rash, swelling, and breathing difficulty.

Before initiating therapy with Venlafaxine Hydrochloride, consider the following precautions. - Cardiovascular assessment: evaluate blood pressure and heart rate regularly. - Serotonin syndrome monitoring: watch for signs of excessive serotonergic activity. - Bipolar disorder screening: avoid use in untreated bipolar patients due to risk of mania. - Hepatic/renal function: adjust use if liver or kidney impairment is present. - Discontinuation: taper gradually under medical supervision to prevent withdrawal symptoms. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Venlafaxine Hydrochloride can interact with several medication classes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Other serotonergic agents (SSRIs, SNRIs, Triptans): increased serotonin toxicity. - Linezolid: combined serotonergic effect may be hazardous.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened bleeding risk. - Anticoagulants (warfarin, DOACs): may enhance anticoagulant effect. - CYP2D6 inhibitors (e.g., fluoxetine, quinidine): can raise venlafaxine plasma levels.